ZA93689B - Antitumor compositions and methods of treatment. - Google Patents

Antitumor compositions and methods of treatment.

Info

Publication number
ZA93689B
ZA93689B ZA93689A ZA93689A ZA93689B ZA 93689 B ZA93689 B ZA 93689B ZA 93689 A ZA93689 A ZA 93689A ZA 93689 A ZA93689 A ZA 93689A ZA 93689 B ZA93689 B ZA 93689B
Authority
ZA
South Africa
Prior art keywords
treatment
methods
antitumor compositions
provides
antitumor
Prior art date
Application number
ZA93689A
Other languages
English (en)
Inventor
George Bernard Boder
Gerald Burr Grindey
John Frederick Worzalla
William Joseph Ehlhardt
John Eldon Toth
John Lyle Zimmermann
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA93689B publication Critical patent/ZA93689B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA93689A 1992-02-05 1993-02-01 Antitumor compositions and methods of treatment. ZA93689B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/831,604 US5254582A (en) 1992-02-05 1992-02-05 Antitumor compositions and methods

Publications (1)

Publication Number Publication Date
ZA93689B true ZA93689B (en) 1994-08-01

Family

ID=25259448

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93689A ZA93689B (en) 1992-02-05 1993-02-01 Antitumor compositions and methods of treatment.

Country Status (25)

Country Link
US (1) US5254582A (fr)
EP (1) EP0555036B1 (fr)
JP (1) JP3210117B2 (fr)
KR (1) KR100246148B1 (fr)
CN (1) CN1044239C (fr)
AT (1) ATE170853T1 (fr)
AU (1) AU658043B2 (fr)
BR (1) BR9300469A (fr)
CA (1) CA2088719A1 (fr)
CY (1) CY2101B1 (fr)
CZ (1) CZ282753B6 (fr)
DE (1) DE69320844T2 (fr)
DK (1) DK0555036T3 (fr)
ES (1) ES2121940T3 (fr)
FI (1) FI930453A (fr)
HU (2) HU213231B (fr)
IL (1) IL104574A (fr)
MX (1) MX9300558A (fr)
MY (1) MY109640A (fr)
NO (1) NO302472B1 (fr)
NZ (1) NZ245818A (fr)
RU (1) RU2072996C1 (fr)
SG (1) SG79181A1 (fr)
YU (1) YU48915B (fr)
ZA (1) ZA93689B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
DE69708340T2 (de) * 1996-08-22 2002-05-16 Dong Wha Pharm Ind Co Ltd Arylsulfonylimidazolon-derivate als antitumormittel
AU4799797A (en) * 1996-10-04 1998-04-24 Eli Lilly And Company Antitumor compositions and methods of treatment
AU6967198A (en) * 1997-04-10 1998-10-30 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US5932407A (en) * 1997-04-30 1999-08-03 Eastman Kodak Company Color photographic element containing oxidized developer-scavenging naphtholic coupler forming wash-out dye
JP4777887B2 (ja) 2003-07-23 2011-09-21 バイエル、ファーマシューテイカルズ、コーポレイション 病気および状態の処置および防止のためのフロロ置換オメガカルボキシアリールジフェニル尿素
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
EP2364699A1 (fr) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Utilisation conjointe d'un composé à base de sulfonamide avec un inhibiteur de l'angiogénèse
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
US20100291592A1 (en) 2006-04-20 2010-11-18 Taro Semba Novel marker for sensitivity against sulfonamide compound
CN104941647B (zh) * 2015-06-18 2017-07-04 四川之江高新材料股份有限公司 合成n‑甲基吗啉的方法及所用的负载型催化剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
US1208561A (en) * 1914-09-14 1916-12-12 Stephen E Huff Sound-box attachment for phonographs.
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
GB1050447A (fr) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
CA1208561A (fr) * 1984-01-19 1986-07-29 Marius S. Brouwer Compose pharmaceutique contenant de la benzoyluree
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JPS6163671A (ja) * 1984-09-05 1986-04-01 Shionogi & Co Ltd ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
CA1331464C (fr) * 1987-05-12 1994-08-16 Eli Lilly And Company Methode et composes antitumoraux
NZ238911A (en) * 1990-07-17 1993-10-26 Lilly Co Eli Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
US5254582A (en) 1993-10-19
CY2101B1 (en) 2002-04-05
HUT63842A (en) 1993-10-28
JPH05306277A (ja) 1993-11-19
HU211561A9 (en) 1995-12-28
DE69320844D1 (de) 1998-10-15
CN1044239C (zh) 1999-07-21
BR9300469A (pt) 1993-08-10
FI930453A (fi) 1993-08-06
MX9300558A (es) 1993-08-01
JP3210117B2 (ja) 2001-09-17
YU5893A (sh) 1996-07-24
CN1075961A (zh) 1993-09-08
AU658043B2 (en) 1995-03-30
AU3218393A (en) 1993-08-12
NO930380L (no) 1993-08-06
DK0555036T3 (da) 1999-06-07
ES2121940T3 (es) 1998-12-16
EP0555036B1 (fr) 1998-09-09
KR930017885A (ko) 1993-09-20
HU9300288D0 (en) 1993-04-28
HU213231B (en) 1997-03-28
CA2088719A1 (fr) 1993-08-06
YU48915B (sh) 2002-11-15
MY109640A (en) 1997-03-31
CZ282753B6 (cs) 1997-09-17
ATE170853T1 (de) 1998-09-15
FI930453A0 (fi) 1993-02-02
EP0555036A3 (en) 1993-11-24
KR100246148B1 (ko) 2000-04-01
DE69320844T2 (de) 1999-03-04
EP0555036A2 (fr) 1993-08-11
CZ12093A3 (en) 1993-12-15
NO930380D0 (no) 1993-02-03
NZ245818A (en) 1995-03-28
RU2072996C1 (ru) 1997-02-10
NO302472B1 (no) 1998-03-09
SG79181A1 (en) 2001-03-20
IL104574A0 (en) 1993-06-10
IL104574A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
IL127244A0 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
HK1013827A1 (en) Protein kinase c inhibitors
CY2101B1 (en) Antitumor compositions and methods of treatment
RU93004535A (ru) Соединения, способ получения и фармацевтическая композиция на их основе
CA2135709A1 (fr) Derives de melatonine servant au traitement des troubles du sommeil
CA2135710A1 (fr) Derives de melatonine servant au traitement des troubles de synchronisation
MY118175A (en) Crystalline pharmaceutical product
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
TH9193B (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
ZA942686B (en) Active compound from a sponge
TH13149A (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
TH13149EX (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
IL100070A0 (en) Tetrahydroisoquinolinyl-carbamates of 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrol(2,3b)indole derivatives and pharmaceutical compositions containing the same